Latest news
Loading news…
Cascadian Therapeutics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Seattle, Washington, United States Founded 1985 51-100 employees For Profit
Cascadian Therapeutics is a bio-pharmaceutical company that researches, develops, and sells therapeutic products for treatment of cancer.
Cascadian Therapeutics on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Cascadian Therapeutics was acquired by Seagen in 2018 for $614M.
Total Funding
$64.9M
Funding Rounds
4
Last Funding
Acquisitions
2
Monthly Visits
Contacts
1
Patents
2
2 trademarks
About Cascadian Therapeutics
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Delisted
- Ticker
- CASC
- Exchange
- NASDAQ
- IPO date
- Jun 9, 2016
- Delisted
- Mar 9, 2018
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 3
- Active products
- 2
- Patents granted
- 2
- Trademarks
- 2
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $8.82M
Company Info
- Founded
- 1985
- Employees
- 51-100
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- News articles
- 34
- HQ
- Seattle, Washington, United States
- Region
- Greater Seattle Area, West Coast, Western US
- Exit date
- Jun 9, 2016
- Closed
- Mar 9, 2018
Signals & Scores
- Heat score
- Low
- Trend (7d)
- 1.5
- Trend (30d)
- 5.6
- Trend (90d)
- 5.5
Cascadian Therapeutics Funding Rounds
4 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–4 of 4Show
Page 1 / 1
Cascadian Therapeutics Acquisitions
2 results
| Acquiree Name | Acquirer Name | Acquiree Industries | Acquiree Hq Country | ||
|---|---|---|---|---|---|
| Alpine Biosciences | $27M | 2014-08-11 | Cascadian Therapeutics | Biotechnology | United States |
| ProlX Pharmaceuticals Corp. | — | 2006-10-01 | Cascadian Therapeutics | BiotechnologyHealth CarePharmaceutical | United States |
1–2 of 2Show
Page 1 / 1
Cascadian Therapeutics Key People
President & CEO
1
professional contacts at Cascadian Therapeutics
Contact execs at Cascadian Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Cascadian Therapeutics
Loading news…
FAQs about Cascadian Therapeutics
People who checked this page also checked these
Sectors Cascadian Therapeutics invests & acquires in
Browse the full Acquirezy directory.